Versant Venture Management, LLC Ocular Therapeutix, Inc Transaction History

Versant Venture Management, LLC

  • $45 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 07, 2021
SELL
$15.82 - $22.11 $23.2 Million - $32.4 Million
-1,465,384 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$7.91 - $22.95 $5.93 Million - $17.2 Million
-750,000 Reduced 33.85%
1,465,384 $30.3 Million
Q3 2017

Oct 13, 2017
BUY
$5.28 - $6.88 $11.7 Million - $15.2 Million
2,215,384
2,215,384 $13.8 Billion

Others Institutions Holding OCUL

# of Institutions
156
Shares Held
139M
Call Options Held
86.4K
Put Options Held
263K
View Full List

About OCULAR THERAPEUTIX, INC

OCUL Quotes by TradingView
  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $853M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Versant Venture Management, LLC Portfolio

Follow Versant Venture Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Venture Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Versant Venture Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email